The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian α-carbonic anhydrase isoforms

Seppo Parkkila, Alessio Innocenti, Heini Kallio, Mika Hilvo, Andrea Scozzafava, Claudiu T. Supuran (Corresponding Author)

Research output: Contribution to journalArticleScientificpeer-review

57 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian α-carbonic anhydrase isoforms'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds